Company: SWAGW
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001213900-25-074995
Chunk: 355

Company: Stran & Company, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 8
Chunk 355
---
    $4.03  
    $— 
  
    Granted 
     45,000  
     1.34  
     — 
  
    Forfeited or expired and other adjustments 
     (17,167) 
     3.72  
     — 
  
    Outstanding at June 30, 2025 
     1,404,166  
    $3.91  
    $16 
  
    Vested and exercisable at June 30, 2025 
     1,261,167  
    $4.02  
    $7 

The
weighted-average remaining contractual term for the options outstanding and exercisable is approximately 6.6 years and 6.5 years, respectively,
as of June 30, 2025.

Restricted Stock

Restricted stock consists of time-based
restricted stock units (“RSUs”) and performance-based restricted stock units (PSUs). RSUs granted under the 2021 Plan generally
vest over 3 to 4 years, based on continued employment, and are settled upon vesting with shares of the Company’s common stock on
a one-for-one basis. PSUs granted under the 2021 Plan are issued and vest immediately as various performance goals and targets are achieved.

A summary of restricted stock activity
under the 2021 Plan as of and for the six months ended June 30, 2025 is presented below:

    Restricted Stock 
    Time-Based 
RSUs 
  
    Outstanding at December 31, 2024 
     4,000 
  
    Granted 
     48,347 
  
    Vested 
     (24,000)
  
    Forfeited 
     — 
  
    Outstanding at June 30, 2025 
     28,347 

N.INCOME (LOSS) PER SHARE:

Basic net income (loss) per share is
computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. The computation
of diluted net income (loss) per share is similar to the computation of basic net income (loss) per share, except that diluted net income
(loss) per share includes the assumed exercise of dilutive warrants and stock options, using the treasury stock method unless the effect
is anti-dilutive. The treasury stock method assumes that proceeds received from the exercise of stock options and warrants would be used
to purchase the Company’s